The treatment of open- and narrow-angle glaucoma.
D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D005123:Eye / Q000473:pathology; D005901:Glaucoma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007429:Intraocular Pressure; D007498:Iris / Q000601:surgery; D010277:Parasympathomimetics / Q000009:adverse effects / Q000627:therapeutic use; D012590:Sclera / Q000601:surgery; D013566:Sympathomimetics / Q000009:adverse effects / Q000627:therapeutic use; D014794:Visual Fields
D002257:Carbonic Anhydrase Inhibitors; D002800:Cholinesterase Inhibitors; D010277:Parasympathomimetics; D013566:Sympathomimetics